The Immunology Biosimilars market size is expected to reach $15.3 billion in 2030 at a CAGR of 12.8%, driven by chronic immune conditions.
Read More
The Immunohematology market size is expected to reach $3.27 billion in 2030 at a CAGR of 5.0%, driven by aging population growth.
Read More
The Immunoglobulins market size is expected to reach $34.52 billion in 2030 at a CAGR of 11.3%, driven by rising healthcare expenditure.
Read More
The Immunoglobulin Fusion Protein market size is expected to reach $87.21 billion in 2030 at a CAGR of 13.6%, driven by autoimmune disorders.
Read More
The Hepatitis B Virus (HBV) Capsid Inhibitors market size is expected to reach $0.98 billion in 2030 at a CAGR of 13.4%, driven by rising HBV infections.
Read More
The Hepatitis B Virus (HBV) market size is expected to reach $11.77 billion in 2030 at a CAGR of 10.2%, driven by high HBV prevalence.
Read More
The global Heparin market size is expected to reach $14.67 billion in 2030 at a CAGR of 7.5%, driven by rising surgical procedures.
Read More
The Heavy Metal Poisoning Drugs market size is expected to reach $2.08 billion in 2030 at a CAGR of 7.4%, driven by growing industrialization.
Read More
The Healthy Aging Supplement market size is expected to reach $2.36 billion in 2030 at a CAGR of 7.4%, driven by increasing health consciousness.
Read More
The Healthcare And Consumer Care Ayurveda Products market size is expected to reach $47.62 billion in 2030 at a CAGR of 18.5%, driven by demand for natural products.
Read More